Furthermore, preliminary studies have shown that C1QBP targeted therapy, such as using anti-C1QBP antibodies in breast cancer [20], and C1QBP inhibitor in glioma [21] have a potential therapeutic value. This evidence concerns the gene C1QBP and central nervous system cancer.